ProKidney Corp.
USD1.90
+0.05 (+2.70%)
CEO
Bruce Culleton
IPO Date
2021-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.89
Prev. Close
$1.85
Day Low
$1.77
Day High
$1.96
52W Low
$0.54
52W High
$7.13
Market Cap
$0.64B
Volume
2.26M
| 135,000 |
| $1.81 |
| 29 May 2026 | Fox Jennifer A. | director | A-Award | Acquired | 135,000 | $1.81 |
| 29 May 2026 | DOYLE WILLIAM F | director | A-Award | Acquired | 135,000 | $1.81 |
| 29 May 2026 | Sinha Uma | director | A-Award | Acquired | 135,000 | $1.81 |
| 29 May 2026 | Legorreta Pablo G. | director, 10 percent owner: | A-Award | Acquired | 135,000 | $1.81 |
| 29 May 2026 | Pereira Brian JG | director | A-Award | Acquired | 135,000 | $1.81 |
| 30 Apr 2026 | Control Empresarial de Capitales S.A. de C.V. | 10 percent owner, other: Add'l Rep. Persons-see Ex.99-1 | C-Conversion | Acquired | 63,118,645 | $0.00 |
| 30 Apr 2026 | Control Empresarial de Capitales S.A. de C.V. | 10 percent owner, other: Add'l Rep. Persons-see Ex.99-1 | C-Conversion | Disposed | 63,118,645 | $0.00 |
| 3 Mar 2026 | Coulston James | Chief Financial Officer | A-Award | Acquired | 600,000 | $2.24 |